Clovis Oncology Inc
Biotechnology
Healthcare
CLVS
144 M shares
NASDAQ US
traded
15 Sep 2022
listed
yes
open
1.40
52 week high
5.85
high
1.41
52 week low
1.36
previous Close
1.39
P/E ratio
market cap
183 M
div yield
0
net incoming
-71.33 M
0.00 %
net profit margin
-7133200000.00 %
0.00 %
operating incoming
-91.52 M
0.00 %
net change in cash
-48.85 M
0.00 %
cash on hand
94.58 M
-22.63 %
cost of revenue
7.87 M
0.00 %
top